YOLFTbeta
30

Remed Co.Ltd

302550 · KQ · Healthcare / Medical Devices

2,625.00KRW+120.00 (+4.79%)

Price History

Full chart

Market Stats

Previous Close2,505.00
Open2,500.00
Day Range2,500.00 – 2,645.00
52-Week Range2,300.00 – 4,070.00
Volume78.29K
Market Cap79.02B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.69
50-Day Avg2,733.40
200-Day Avg2,907.28

About

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Geun-Yong Lee
  • Employees88
  • HeadquartersNo. 301- 303, 187 Techno2-ro, Daejeon, South Korea, 34025, Korea
  • Websitehttps://remed.kr

Leadership

  • Mr. Geun-Yong LeeChief Executive Officer · b. 1968
  • Tae-gun KimChief Technology Officer

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.24B8.00B18.55B16.63B20.20B21.36B18.54B25.55B24.50B
Growth (%)-+28.24%+131.76%-10.34%+21.42%+5.79%-13.23%+37.86%-4.11%
Cost of Revenue2.83B4.01B7.87B7.99B9.78B10.17B9.50B11.38B10.42B
Gross Profit3.41B4.00B10.68B8.64B10.41B11.19B9.03B14.17B14.08B
Gross Margin54.70%49.94%57.55%51.95%51.55%52.39%48.73%55.47%57.46%
Operating Expense3.08B4.83B6.37B6.96B9.26B9.53B7.90B13.32B13.36B
Operating Income336.53M-828.93M4.31B1.68B1.15B1.66B1.13B852.31M725.84M
Operating Margin5.39%-10.36%23.24%10.12%5.68%7.78%6.11%3.34%2.96%
EBITDA-----6.28B3.18B10.50B1.99B
EBITDA Margin-----29.41%17.15%41.08%8.14%
Net Income36.24M-7.38B4.36B-1.83B752.33M4.00B797.17M7.17B526.20M
Net Income Margin0.58%-92.21%23.52%-11.02%3.73%18.72%4.30%28.07%2.15%
R&D---2.29B2.73B2.43B2.94B3.48B3.29B
R&D as % of Total Revenue---13.76%13.52%11.36%15.86%13.63%13.41%
Interest Expense000416.03M775.51M966.80M1.24B1.17B876.57M
Interest Expense % of Total Revenue0.00%0.00%0.00%2.50%3.84%4.53%6.71%4.59%3.58%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.59B21.51B34.95B73.47B77.20B78.13B55.06B59.06B53.91B
Total Liabilities8.41B10.57B10.32B48.68B51.10B48.21B24.27B18.81B14.45B
Total Equity4.19B10.94B24.62B24.79B26.10B29.92B30.83B40.25B40.07B
Cash304.00K-15.22B10.48B470.00K200.00K4.75B378.00K8.47B
Total Debt--5.86B18.89B-----
Net Debt---8.36B9.20B14.13B11.65B1.83B-

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow66.75M-317.96M3.22B2.59B-3.49B5.21B3.50B1.24B2.40B
Investing Cash Flow-1.19B-7.67B535.27M-43.67B2.90B-10.20B21.06B6.47B-
Financing Cash Flow2.78B8.52B8.12B36.68B489.58M-9.29M-25.00B-6.79B-
Capital Expenditure768.89M5.01B2.01B679.62M4.88B4.77B893.97M608.80M868.76M
Free Cash Flow----6.27B-4.12B-5.62B2.60B635.72M1.53B
FCF to OCF----241.96%118.11%-107.75%74.45%51.08%63.75%

Earnings

Report DateJan 28, 2020May 21, 2020Aug 31, 2020Nov 13, 2020Feb 15, 2021May 31, 2021Aug 27, 2021Nov 17, 2021Feb 11, 2022May 13, 2022Aug 12, 2022Nov 11, 2022Feb 8, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------
EPS Actual330.74474.0012.009.00-775.3017.8456.3681.00-220.4499.8059.37227.00-235.818.93-27.6337.157.57-2.7134.93118.9471.9514.85-9.5814.36-6.8336.225.18
Surprise---------------------------
TimingAfter-hoursPre-market-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market--------------

Key Statistics & Ratios

Market Cap79.02B
Enterprise Value73.19B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.92
Price / Book2.03
Revenue (TTM)27.05B
Gross Profit (TTM)15.10B
EBITDA3.39B
Profit Margin7.58%
Operating Margin12.83%
Return on Equity3.02%
Return on Assets2.26%
Shares Outstanding30.28M
Shares Float18.60M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 26, 20235:1